Recently published studies revealed that human non-cleavable RIPK1 variants promoted activation of RIPK1, and led to an increased inflammatory response in PBMCs, which resulted in an early-onset periodic fever syndrome and severe intermittent lymphadenopathy (13, 14). The gene discussed is RIPK1; the disease is Lymphadenopathy.